Purine Nucleosides Bearing 1-Alkynyl Chains as Adenosine Receptor Agonists

E-ISSN： 1873-4286|8|26|2285-2298

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.26, 2002-12, pp. : 2285-2298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A1 and A3 adenosine receptor agonists: an overview

By Baraldi P.G. Cacciari B. Romagnoli R. Spalluto G.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 515-527

Informa Healthcare

Access to resources Recommend Favorite

A₁ adenosine receptor agonists and their potential therapeutic applications

By Elzein Elfatih Zablocki Jeff

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1901-1910

Informa Healthcare

Access to resources Recommend Favorite

Emerging adenosine receptor agonists

By Gao Zhan-Guo Jacobson Kenneth A

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 479-492

Informa Healthcare

Access to resources Recommend Favorite

Adenosine receptor agonists

By Jacobson Marlene A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 489-501

Informa Healthcare

Access to resources Recommend Favorite

Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A₁-Receptor Agonists

By van Schaick Erno A. de Greef Henrik J. M. M. Ijzerman Adriaan P. Danhof Meindert

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 673-694

Springer Publishing Company

Access to resources Recommend Favorite